(19)
(11) EP 4 076 402 A1

(12)

(43) Date of publication:
26.10.2022 Bulletin 2022/43

(21) Application number: 20835800.2

(22) Date of filing: 18.12.2020
(51) International Patent Classification (IPC): 
A61K 9/16(2006.01)
A61K 31/7048(2006.01)
 A61K 9/20(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/1635; A61K 9/1652; A61K 9/2009; A61K 9/2054; A61K 31/7048
(86) International application number:
PCT/EP2020/087022
(87) International publication number:
WO 2021/123165 (24.06.2021 Gazette 2021/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 19.12.2019 EP 19218238

(71) Applicant: KRKA, d.d., Novo mesto
8501 Novo mesto (SI)

(72) Inventors:
  • RATEK, Gregor
    8501 Novo mesto (SI)
  • ZUPANCIC, David
    8501 Novo mesto (SI)
  • KORASA, Klemen
    8501 Novo mesto (SI)
  • SMRKOLJ, Matej
    8501 Novo mesto (SI)
  • KOLENC, Ivanka
    8501 Novo mesto (SI)
  • SVETIC, Sandi
    8501 Novo mesto (SI)
  • POLOVIC, Ale
    8501 Novo mesto (SI)
  • AVSENIK, Rok
    8501 Novo mesto (SI)

(74) Representative: Kutzenberger Wolff & Partner 
Waidmarkt 11
50676 Köln
50676 Köln (DE)

   


(54) DOSAGE FORM COMPRISING AMORPHOUS SOLID SOLUTION OF EMPAGLIFLOZIN WITH POLYMER